SCHEMBL4854885

SCHEMBL4854885

Cc1ccccc1-c1ccc(OCCN2CCCC2)c(C=O)c1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.56
ESR1 P03372 2/20 0.50
ESR2 Q92731 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
KDM4E B2RXH2 3/20 0.48
LTA4H P09960 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
HRH1 P35367 3/20 0.46
DRD1 P21728 2/20 0.46
DRD4 P21917 2/20 0.46
DRD5 P21918 2/20 0.46
DRD3 P35462 2/20 0.46
ALDH1A1 P00352 1/20 0.46
DRD2 P14416 1/20 0.45
MCHR1 Q99705 1/20 0.45
BACE1 P56817 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849189 0.93 CYP2D6 (0.53) TDP1CYP2D6CYP2C19KDM4EMEN1
SCHEMBL4856576 0.92 CYP2D6 (0.52) TDP1CYP2D6CYP2C19KDM4EMEN1
SCHEMBL4845580 0.78 SLC6A9 (0.49) ESR1SMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL4852186 0.77 SLC6A9 (0.46) CYP2D6CYP2C19KDM4EMEN1KMT2A
SCHEMBL6141526 0.77 SSTR2 (0.39) KDM4EMEN1KMT2AALDH1A1
SCHEMBL4852464 0.77 BACE1 (0.50) TDP1ESR1ESR2SMN1; SMN2KDM4E
SCHEMBL1892119 0.77 MEN1 (0.63) TDP1SMN1; SMN2CYP2D6CYP2C19KDM4E
SCHEMBL4854461 0.76 DRD2 (0.46) KDM4EMEN1KMT2ADRD1DRD3
SCHEMBL4854976 0.76 CYP1A2 (0.47) SMN1; SMN2CYP2D6CYP2C19KDM4EMEN1
SCHEMBL4855017 0.76 KDM4E (0.49) SMN1; SMN2KDM4EMEN1KMT2AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed